|Description||BI 6015 is a hepatocyte nuclear factor 4α (HNF4α) antagonist that suppresses expression of known HNF4α target genes. BI 6015 produces cytotoxicity in a range of tumor cell lines, including human hepatocellular carcinoma.|
|Brife Description||HNF4α antagonist|
|Purity||≥98% by HPLC|
|Synonyms||BI6015; BI 6015; BI-6015. 2-Methyl-1-[(2-methyl-5-nitrophenyl)sulfonyl]-1H-benzimidazole|
Sulofenur is a diarylsulfonylurea with potential antineoplastic activity, whose antineoplastic mechanism of action is unknown.
Lotilaner is an insecticide and veterinary drug.
Pipazetate, as a cough suppressant, is a non-narcotic oral antitussive agent acting centrally on the medullary cough center.
ISA-2011B is a Phosphatidylinositol-4-phosphate 5-kinase-α (PIP5Kα) inhibitor. Research shows that the overexpression of PIP5K1α is associated with poor prognos...
GPi 688 is an allosteric glycogen phosphorylase inhibitor that inhibits glucagon-mediated hyperglycemia in the rat.
AZ PFKFB3 67
AZ PFKFB3 67 is a selective and novel metabolic kinase PFKFB3 inhibitor with IC50 value of 11 μM.
4-(Trifluoromethyl)phenylboronic acid is a very useful building block for chemical synthesis
CTX-0294885 is a novel broad-spectrum kinase inhibitor. CTx-0294885 exhibits inhibitory activity against a broad range of kinases in vitro. Use of a quantitativ...